[NBY] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
07-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -39.87%
YoY- -26.18%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,424 3,255 3,826 1,840 2,170 1,615 3,142 -4.22%
PBT -2,217 -1,757 -136 -2,289 -3,221 -282 -1,538 6.27%
Tax 0 -51 -321 -1 1,588 -2,149 -267 -
NP -2,217 -1,757 -5,793 -2,289 -3,221 -282 -1,538 6.27%
Tax Rate - - - - - - - -
Total Cost 4,641 5,012 9,619 4,129 5,391 1,897 4,680 -0.13%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -91.46 -53.98 -151.41 -124.40 -148.43 -17.46 -48.95 10.96%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.60 -13.11 -126.40 -62.42 -98.55 -14.96 -110.25 -58.02%
EPS Diluted -0.60 -13.11 -126.40 -62.42 -98.55 -18.84 -128.95 -59.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.